Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You really think AVXL dropping 3.7% while SAVA rose 9% had ANYTHING to do with true value?
Setting em up perfectly.
Watch the video to understand
Look at this p2 blood analysis to confirm this is how it works, what gets affected.
Here is our Alz data for confirmation.
Here is the OLE where A-273 even benefits the placebo group.
Rett, “undisclosed indication” same idea.
We may have that once in decade opportunity to be part of an amazing run soon.
$10 today could possibly be 300,400,500+ in a few years.
Yet the naysayers will still be beating that drum. But Missling is still…..
That are yet to be approved
Funny isn’t it. If Missling happened to release any data recently, Anavex would have been paired with SAVA as possibly having skewed data.
It would have been spun that way.
All quiet on the western front
Sure…. Hard to claim when it’s spread over multiple trials, not just 1.
SAVA, Amyloid, Western blots, and fabrication.
Intriguing
Sounds like the chances of another BIIB Alz approval is going down the drain.
Anything only targeting Amyloid clearing….pull em all!!!
Possible.
I recall Missling saying P3 just confirms what you were looking for in the previous trial.
Yet for some reason, here we are in the 12s.
What an amazing opportunity retail investors have.
Bringing up some old news that many probably forgot about
https://act-ad.org/q-a-with-anavex/
Our lead compound, ANAVEX 2-73 is an orally available drug candidate that targets sigma-1 and muscarinic receptors. Our research shows sigma-1 receptors to be the key cellular survival proteins in neurodegenerative diseases. Our drug therapeutic targets the sigma-1 receptor in order to activate a “Quality Control.”
Q: What is your take on the current state of Alzheimer’s research?
A: I understand that the research resources available for Alzheimer’s are still much lower than for cancer. Regarding the clinical development, the recent clinical trials targeting and reducing Abeta directly, unfortunately, did not show fully positive outcomes. What we believe we are doing differently is that we are trying to aim for the potential cause of the Abeta aggregation, not just to target Abeta. We believe our drug is targeting the disease in a more upstream manner and possibly addressing the cause of the disease.
It is also important to point out we are a small company, not a big pharmaceutical commercializing drugs. We realize wall these trial failures have led to some fear in treating this area. Although recent trial disappointments have occurred; research should not be restricted, rather further supported. We are happy there are organizations such as ACT-AD helping get this voice out there.
https://www.anavex.com/press-releases/-anavex-life-sciences-to-present-at-the-5th-annual-mental-health-parity-addiction-equity-act-business-roundtable-in-washington%2C-dc
“It is important for panelists such as Dr. Missling to attend in order to lend his expertise in developing therapies for diseases such as Alzheimer’s disease as well as other neurological disorders with high unmet needs.”
The Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) requires group health plans and health insurance issuers to ensure that financial requirements (such as co-pays, deductibles) and treatment limitations (such as visit limits) applicable to mental health or substance use disorder (MH/SUD) benefits are no more restrictive than the predominant requirements or limitations applied to substantially all medical/surgical benefits.
Why do you think there will be a buyout? If Rett is approved, the rest of the dominoes will fall in place and a new BP will be born.
Then there’s 3-71
Look at SAVA Riding the coattails of AVXL these days.
Lower your expectations and be surprised when something does happen.
Who knows… it may be possible something huge is in the works….. or maybe the company is just moving methodically.
True, then again….it’s only $850 at the moment.
Was a great opportunity to build up those custodial accounts for the kids these last few weeks.
What a nice graduation gift it will be for them beginning in 3 years.
Why would you even take a message board post as fact when one can look it up
https://fintel.io/so/us/acad/baker-bros-advisors-lp
And see that they still have it as of 3/31/22
Best relief for PDD works for me.
Hump day?
I’ve been off the board for a few months and can’t believe how pegged we are to that other co. still.
what was it 2 or 3 p3 readouts within the next 12 months and still competing against one that hope to fully enroll their p3 at that time?
Yea, the slow switcharoo will happen soon and never look back.
So glad I was able to add some on the cheap into my 401 and Roth accounts the last 2 weeks
The positive is that he explained why Excellence was still trying to fill enrollment.
It was something we didn’t know, which now we know.
The potential is mind boggling, yet here we are not even back to the teens.
Everyone wants a get rich quick scheme.
Anavex is not it.
It is however, a wise long term investment if one can purchase and “fogettaboudit”
This coming from someone that “mined” dogecoin the minute it was live and sold the night before Elon went on SNL
Spot on e2w.
Can we have some cheese with those whiners.
We all know what would happen if another ceo were to take over. They’d sell out, which is probably what some of them would probably want done cheaply.
Missling is doing just fine. Slow and steady wins the race.
Tutes want someone that will DO as they say!!
I’d rather have someone that bucks the trend.
Tiny studies, 500+ enrolled, with BIG results outweigh large studies with meh….results
I’m sure it was for some, while others were here to see the $16-$1s a few years ago.
With English not being his first language, I’m sure he fumbled that question with free for the trial participants and the expanded access.
Guess like everything else, we’ll find out when we find out.
A-273 is craze right now.
A-371 is a more 5-10 year plan. At least for Alzheimer’s it is.
Right. While some try to create panic….it is a great opportunity to add on the cheap.
Right…… keep kidding yourself there.
You think we bordering single digits for fun? We down here because someone wants Anavex down here. $1B is a drop in the bucket for BP and they are fully aware of the risks Anavex creates for their future.
Now now…..let’s not let the topic be of the guy that tweets bs.
Let the topic be Anavex and what’s up next.
Isn’t Missling attending a conference in a few weeks?
Curious how March will be as well when patients can be heard on possible treatments for Rett
Come on now….you think ws would just fork over their money?
The only thing I’m concerned about is how low the MC is. Anavex probably has vultures circling above waiting to pounce.
Who wants to bet Australia gets Blarcamesine to market first?
So….either way AF had his hit piece ready to go.
They left it, he would have pounced on the fact that it’s not a reliable measurement and blah blah blah.
Was thinking the same thing. I have enough shares for now…..but if we enter single digits…man that’s easy money if you the patient type.
Damaged shareholder value temporarily. Like it or not, HE will get Anavex across the finish line.
Whether you are still in or not, that’s a decision each person individually makes.
Im patiently waiting for my shares to reach 10x or more on top of the almost 10x already achieved….welp now it’s 9x…. Nope, back up…
Funny how the group that would like Missling replaced is the same group that would sell to BP on the cheap.
Need shares to even have a say guys!!
We will ALWAYS be attacked all the way up to and including AD results.
New MOA with never before seen readouts scare everyone that has influence. Especially foolish BPs that followed the white rabbit down the hole for the last few decades. DECADES with nothing to show but mass amounts of failure.
Mr Twitter will never admit it, but IMHO he is paid by a “dark BP”
If we follow their playbook, after a short attack is when the fake lawsuits start.
Like a game of poker, with Rett, PD, and AD in our hand close to the chest….
We have one card on the flop. Tic toc, only time before we get more…..
Games obviously are played in this high stakes game.
Woke up and was like wow….we must of had good news
Come on plex. Same can be said for 6 cups of coffee.
Now that p2 changed to a p3 for Rett, soon we shall see what Missling meant by iceberg way back when.
That’s the conclusion I got as well with the placebo rolling right into taking the actual pills. Don’t know why but that sounds familiar, like maybe Missling said that somewhere over the last 6 years.
Then again…..could be wrong
Quick……what’s your response.